IBEX (IBEX) Competitors $25.04 +0.55 (+2.25%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$25.59 +0.55 (+2.20%) As of 08:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IBEX vs. IBTA, DFIN, LZ, TASK, UPBD, XMTR, FLYW, EVH, NVEE, and OLOShould you be buying IBEX stock or one of its competitors? The main competitors of IBEX include Ibotta (IBTA), Donnelley Financial Solutions (DFIN), LegalZoom.com (LZ), TaskUs (TASK), Upbound Group (UPBD), Xometry (XMTR), Flywire (FLYW), Evolent Health (EVH), NV5 Global (NVEE), and OLO (OLO). These companies are all part of the "business services" industry. IBEX vs. Ibotta Donnelley Financial Solutions LegalZoom.com TaskUs Upbound Group Xometry Flywire Evolent Health NV5 Global OLO IBEX (NASDAQ:IBEX) and Ibotta (NYSE:IBTA) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Does the media prefer IBEX or IBTA? In the previous week, Ibotta had 23 more articles in the media than IBEX. MarketBeat recorded 31 mentions for Ibotta and 8 mentions for IBEX. IBEX's average media sentiment score of 0.58 beat Ibotta's score of 0.03 indicating that IBEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IBEX 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ibotta 1 Very Positive mention(s) 3 Positive mention(s) 26 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in IBEX or IBTA? 81.2% of IBEX shares are owned by institutional investors. 6.7% of IBEX shares are owned by insiders. Comparatively, 16.1% of Ibotta shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is IBEX or IBTA more profitable? IBEX has a net margin of 7.08% compared to Ibotta's net margin of 0.00%. IBEX's return on equity of 25.29% beat Ibotta's return on equity.Company Net Margins Return on Equity Return on Assets IBEX7.08% 25.29% 13.16% Ibotta N/A N/A N/A Do analysts recommend IBEX or IBTA? IBEX currently has a consensus price target of $25.00, suggesting a potential downside of 0.16%. Ibotta has a consensus price target of $50.00, suggesting a potential upside of 2.56%. Given Ibotta's stronger consensus rating and higher probable upside, analysts clearly believe Ibotta is more favorable than IBEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IBEX 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Ibotta 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings & valuation, IBEX or IBTA? Ibotta has lower revenue, but higher earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than Ibotta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIBEX$521.73M0.63$33.65M$2.1311.76Ibotta$367.25M4.12$55.53M$1.7927.23 Does the MarketBeat Community believe in IBEX or IBTA? IBEX received 32 more outperform votes than Ibotta when rated by MarketBeat users. However, 100.00% of users gave Ibotta an outperform vote while only 41.77% of users gave IBEX an outperform vote. CompanyUnderperformOutperformIBEXOutperform Votes3341.77% Underperform Votes4658.23% IbottaOutperform Votes1100.00% Underperform VotesNo Votes SummaryIBEX and Ibotta tied by winning 8 of the 16 factors compared between the two stocks. Get IBEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBEX vs. The Competition Export to ExcelMetricIBEXData processing & preparation IndustryBusiness SectorNASDAQ ExchangeMarket Cap$330.33M$3.93B$7.30B$7.82BDividend YieldN/A3.84%2.58%4.22%P/E Ratio11.7666.9530.7118.48Price / Sales0.63792.75172.23103.60Price / Cash8.0833.7431.5134.62Price / Book3.036.165.034.25Net Income$33.65M$42.75M$195.49M$248.23M7 Day Performance1.95%3.21%0.76%0.89%1 Month Performance-0.44%3.27%3.57%3.53%1 Year Performance88.55%11.46%12.65%5.08% IBEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBEXIBEX1.5872 of 5 stars$25.04+2.2%$25.00-0.2%+91.1%$330.33M$521.73M11.7630,000Upcoming EarningsIBTAIbotta0.5873 of 5 stars$45.67-4.2%$50.00+9.5%N/A$1.20B$367.25M25.51N/ADFINDonnelley Financial Solutions3.7408 of 5 stars$41.77-0.4%$71.33+70.8%-23.1%$1.19B$781.90M13.652,150Earnings ReportAnalyst ForecastNews CoveragePositive NewsLZLegalZoom.com3.2767 of 5 stars$6.61-4.8%$9.06+37.1%-38.7%$1.16B$681.88M50.851,220Upcoming EarningsShort Interest ↓Gap DownTASKTaskUs3.0797 of 5 stars$12.80-1.2%$17.86+39.5%+21.8%$1.15B$994.99M21.6949,500Upcoming EarningsShort Interest ↓News CoverageUPBDUpbound Group4.358 of 5 stars$19.99-2.7%$37.00+85.1%-35.8%$1.15B$4.32B9.0512,700Positive NewsXMTRXometry3.0997 of 5 stars$22.18+0.6%$36.11+62.8%+43.5%$1.12B$545.53M-21.12790Upcoming EarningsAnalyst ForecastNews CoverageFLYWFlywire4.0105 of 5 stars$8.62-2.9%$17.00+97.2%-54.1%$1.07B$492.14M57.47660Upcoming EarningsShort Interest ↑EVHEvolent Health2.7319 of 5 stars$8.52-4.9%$17.64+107.1%-64.5%$993.36M$2.55B-10.395,100Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsNVEENV5 Global3.3218 of 5 stars$15.12-4.4%$25.67+69.8%-20.4%$986.25M$941.27M30.703,640News CoveragePositive NewsGap UpOLOOLO3.4804 of 5 stars$5.86-3.3%$8.67+47.9%+29.6%$972.85M$284.94M-58.59710Upcoming Earnings Related Companies and Tools Related Companies IBTA Competitors DFIN Competitors LZ Competitors TASK Competitors UPBD Competitors XMTR Competitors FLYW Competitors EVH Competitors NVEE Competitors OLO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IBEX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.